6-K 1 dp70994_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December, 2016

 

 

 

Commission File Number: 001-13742

 

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

 

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X 

 

Form 40-F

 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes

 

 

No

X 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes

 

 

No

X

 

 





 

ISRAEL CHEMICALS LTD.

 

 INCORPORATION BY REFERENCE

 

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 





ISRAEL CHEMICALS LTD.

 

 

1.

Withdrawal of Appeal over Tax Assessment

 

 

 




 Item 1

 

 

Withdrawal of Appeal over Tax Assessment

 

Further to the Company's immediate report dated December 31, 2013, and to Note 20D of the Company's annual financial statements for 2015, regarding an assessment by the Israeli Tax Authority, the Company hereby reports that it withdrew the appeal filed on February 2015 in respect of the aforementioned tax assessment. The additional tax for payment, in excess of the amounts already paid by the Company to date, is NIS 228 million (about $60 million), including interest and linkage as of the date of this report. Accordingly, the Company is expected to update the provisions booked in its financial statements for the fourth quarter and for 2016 in the amount of about NIS 130 million (about $34 million).

 

 





 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Israel Chemicals Ltd.

 

 

 

 

 

 

By:

/s/ Kobi Altman

 

 

 

 

Name:

Kobi Altman

 

 

 

 

Title:

Chief Financial Officer

 

 

 

Israel Chemicals Ltd.

 

 

 

 

 

 

By:

/s/ Lisa Haimovitz

 

 

 

 

Name:

Lisa Haimovitz

 

 

 

 

Title:

Senior Vice President, Global General Counsel and Corporate Secretary

 

Date: December 8, 2016